-
Add to Cart The item has been addedrp143422-100μgRecombinant Human BTN3A2 Protein (C007B-551610)
Price: $802.58List Price: $891.76FunctionPlays a role in T-cell responses in the adaptive immune response. Inhibits the release of IFNG from activated T-cells. -
Add to Cart The item has been addedrp143422-50μgRecombinant Human BTN3A2 Protein (C007B-551613)
Price: $529.81List Price: $588.68FunctionPlays a role in T-cell responses in the adaptive immune response. Inhibits the release of IFNG from activated T-cells. -
Add to Cart The item has been addedAb170556-100μgSimtuzumab (anti-LOXL2) (C007B-327569)
Price: $103.67List Price: $115.19Simtuzumab (anti-LOXL2) is a monoclonal antibody directed against Lysyl oxidase like-2 (LOXL2). Simtuzumab (anti-LOXL2) can be used for the research of primary sclerosing cholangitis (PSC).Purity：>:95% (SDS-PAGE&:SEC)Endotoxin Level<: -
Add to Cart The item has been addedAb170556-10mgSimtuzumab (anti-LOXL2) (C007B-327570)
Price: $1,274.47List Price: $1,416.08Simtuzumab (anti-LOXL2) is a monoclonal antibody directed against Lysyl oxidase like-2 (LOXL2). Simtuzumab (anti-LOXL2) can be used for the research of primary sclerosing cholangitis (PSC).Purity：>:95% (SDS-PAGE&:SEC)Endotoxin Level<: -
Add to Cart The item has been addedAb170556-1mgSimtuzumab (anti-LOXL2) (C007B-327571)
Price: $346.27List Price: $384.74Simtuzumab (anti-LOXL2) is a monoclonal antibody directed against Lysyl oxidase like-2 (LOXL2). Simtuzumab (anti-LOXL2) can be used for the research of primary sclerosing cholangitis (PSC).Purity：>:95% (SDS-PAGE&:SEC)Endotoxin Level<: -
Add to Cart The item has been addedAb170556-5mgSimtuzumab (anti-LOXL2) (C007B-327572)
Price: $800.15List Price: $889.05Simtuzumab (anti-LOXL2) is a monoclonal antibody directed against Lysyl oxidase like-2 (LOXL2). Simtuzumab (anti-LOXL2) can be used for the research of primary sclerosing cholangitis (PSC).Purity：>:95% (SDS-PAGE&:SEC)Endotoxin Level<: -
Add to Cart The item has been addedS649712-10mgSKLB-197 (C007B-418493)
Price: $453.55List Price: $503.94SKLB-197 showed an IC 50 value of 0.013 μM against ATR but very weak or no activity against other 402 protein kinases. It displayed potent antitumor activity against ATM-deficent tumors both in vitro and in vivo.Form:SolidIC50&: Target:ATR 0.013 -
Add to Cart The item has been addedS649712-25mgSKLB-197 (C007B-418494)
Price: $852.45List Price: $947.16SKLB-197 showed an IC 50 value of 0.013 μM against ATR but very weak or no activity against other 402 protein kinases. It displayed potent antitumor activity against ATM-deficent tumors both in vitro and in vivo.Form:SolidIC50&: Target:ATR 0.013 -
Add to Cart The item has been addedS649712-50mgSKLB-197 (C007B-418495)
Price: $1,363.26List Price: $1,514.73SKLB-197 showed an IC 50 value of 0.013 μM against ATR but very weak or no activity against other 402 protein kinases. It displayed potent antitumor activity against ATM-deficent tumors both in vitro and in vivo.Form:SolidIC50&: Target:ATR 0.013 -
Add to Cart The item has been addedAb176390-100μgSonepcizumab (anti-Sphingosine-1-phosphate) (C007B-328499)
Price: $190.21List Price: $211.35Sonepcizumab (anti-Sphingosine-1-phosphate) is a fully humanized anti-S1P monoclonal antibody. Sonepcizumab (anti-Sphingosine-1-phosphate) has the potential for the research of metastatic renal cell carcinoma (mRCC).Purity>:95% -
Add to Cart The item has been addedAb176390-10mgSonepcizumab (anti-Sphingosine-1-phosphate) (C007B-328500)
Price: $2,583.00List Price: $2,870.00Sonepcizumab (anti-Sphingosine-1-phosphate) is a fully humanized anti-S1P monoclonal antibody. Sonepcizumab (anti-Sphingosine-1-phosphate) has the potential for the research of metastatic renal cell carcinoma (mRCC).Purity>:95% -
Add to Cart The item has been addedAb176390-1mgSonepcizumab (anti-Sphingosine-1-phosphate) (C007B-328501)
Price: $656.64List Price: $729.59Sonepcizumab (anti-Sphingosine-1-phosphate) is a fully humanized anti-S1P monoclonal antibody. Sonepcizumab (anti-Sphingosine-1-phosphate) has the potential for the research of metastatic renal cell carcinoma (mRCC).Purity>:95%
